Results
1 -
10 of
13
(Click
here to explore results)
The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 2, CHAPTER 1 In Silico Approaches for Drug Repurposing for SARS-CoV-2 Infection . Sudhir A. Kulkarni, Kundan Ingale
, 2022
, Volume 2
, Pages 1-80
Successful Strategies for the Discovery of Antiviral Drugs, CHAPTER 6 HIV Integrase Inhibitors . Brian A. Johns, Takashi Kawasuji, Emile J. Velthuisen
, 2013
, Pages 149-188
Successful Strategies for the Discovery of Antiviral Drugs, Subject index
, 2013
, Pages 509-534
DNA-targeting Molecules as Therapeutic Agents, Chapter 2 Interfacial Inhibitors . Evgeny Kiselev, Yves Pommier
, 2018
, Pages 33-44
Amino Acids, Peptides and Proteins: Volume 41, Peptide-derived mid-sized anti-HIV agents . Nami Ohashi, Hirokazu Tamamura
, 2017
, Volume 41
, Pages 1-29
Successful Strategies for the Discovery of Antiviral Drugs, Contents
, 2013
, Pages P009-P016
Antiviral Discovery for Highly Pathogenic Emerging Viruses, Chapter 1 Overview of Antiviral Drug Discovery and Development: Viral Versus Host Targets . Guangdi Li, Erik De Clercq
, 2022
, Pages 1-27
Successful Strategies for the Discovery of Antiviral Drugs, CHAPTER 14 Clinical Benefits of Single‐tablet Regimens . Danielle P. Porter, Bill Guyer
, 2013
, Pages 482-508
Green Synthetic Processes and Procedures, CHAPTER 4 Flow Chemistry in Drug Discovery . J. Alcazar, A. de la Hoz, A. Díaz-Ortiz
, 2019
, Pages 53-78
Specialised Pharmaceutical Formulation: The Science and Technology of Dosage Forms, Chapter 10 Development Programs for Oral Fixed Dose Combination Products . Patrick J. Crowley, Sharon M. Maglennon, Luigi G. Martini, David Templeton
, 2022
, Pages 259-286